In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease, has appointed Rafael Amado as chief medical officer and Adrian Rawcliffe as chief financial officer. 4 March 2015
Pharmaceutical
Canadian cannabinoid therapy specialist InMed Pharmaceuticals has appointed Ado Mohammed as chief medical officer. 4 March 2015
article
French drug maker Ipsen has appointed Dominique Laymand as senior vice president, chief ethics and compliance officer for the group. 4 March 2015
Pharmaceutical
Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer. 4 March 2015
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has promoted Christophe Weber from representative director, president and chief operating officer to representative director, president and chief executive officer. 4 March 2015
Biotechnology
Jeffrey Barrett has been appointed the founding director for the Centre for Therapeutic Target Validation, a public-private partnership between GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute. 2 March 2015
Pharmaceutical
The former chief executive of French pharma major Sanofi Christopher Viehbacher has been appointed to the board of directors of US R&D company PureTech. 27 February 2015
Pharmaceutical
Japanese drug major Astellas Pharma is to make organizational and personnel changes in the Americas, as well as streamlining business development globally. 20 February 2015
Pharmaceutical
Confirming what the media had been saying most of the week, French pharma major Sanofi late yesterday said that Olivier Brandicourt will become the firm’s chief executive, effective April 2. 20 February 2015
Biotechnology
Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne Hyland as chief financial officer. 19 February 2015
Pharmaceutical
Dutch pharma company Pharming has appointed Perry Calias as chief scientific officer. 18 February 2015
Pharmaceutical
UK pharma major GlaxoSmithKline has named Jack Bailey as president of its US pharma unit. 17 February 2015
Pharmaceutical
Israel-based Immune Pharmaceuticals has appointed Paul Nadler as acting executive vice president of research and development, and chief medical officer. 9 February 2015
Pharmaceutical
Autologous T-cell therapy product specialist Kite Pharma has appointed Salah Kivlighn as vice president of marketing and Anthony Polverino as vice president of research. 4 February 2015
article
Biopharma company Lycera has appointed Paul Sekhri as president and chief executive. 3 February 2015
Pharmaceutical
Swiss pharma company Santhera has expanded its leadership team, appointing existing senior staff members Nicholas Coppard as senior vice president head of development, Günther Metz as senior vice president business development, and Oliver Strub, general counsel and secretary to the board. 2 February 2015
Biotechnology
US biotech major Gilead Sciences has promoted Andrew Cheng to executive vice president of HIV therapeutics and development operations, and Taiyin Yang to executive vice president of pharmaceutical development and manufacturing. 29 January 2015
Pharmaceutical
Switzerland-headquartered Ferring Pharmaceuticals has appointed Pascal Danglas as executive vice president and chief medical officer, and Per Falk has been appointed executive vice president and chief scientific officer. 28 January 2015
Pharmaceutical
Canadian medical marijuana therapy specialist T-Bird Pharma has appointed Sandy Pratt as chief financial officer. 27 January 2015
Pharmaceutical
Belgian pharma company Promethera Biosciences has announced the resignation of its chief executive Eric Halioua. 23 January 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze